BPC157 & TB500 32 contains 32 mg total of two synergistic peptides. 16 mg BPC-157 and 16 mg TB-500—per pen. This pen is capable of dispensing precise doses of 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg (delivering equal parts of each peptide per dose) for flexible administration based on research or practitioner instruction.
This compound is intended for research use only. It should only be handled by qualified professionals in appropriate settings.
- If you have further questions, consult your healthcare provider or research supervisor.
1. What BPC157 & TB500 32 is and what it is used for
BPC157 & TB500 32 is a dual-peptide injectable research compound combining:
- BPC-157: A pentadecapeptide derived from a protein found in the stomach, known for its role in tissue repair, angiogenesis, and reducing inflammation.
- TB-500 (Thymosin Beta-4 fragment): A synthetic version of a naturally occurring peptide that promotes regeneration, cell migration, and wound healing.
Key Research Applications:
- Accelerating recovery of muscles, tendons, ligaments, and joint tissue
- Reducing inflammation in injured tissues
- Supporting vascular and connective tissue healing
- Promoting repair of soft tissue, even under stress
- Increasing flexibility and mobility post-injury
The combination of BPC157 and TB500 offers a synergistic effect—amplifying tissue regeneration, enhancing recovery time, and offering systemic repair properties.
2. What you need to know before using BPC157 & TB500 32
Do not use BPC157 & TB500 32 if you:
- Are allergic to either peptide or any excipients in the formulation
- Are pregnant or breastfeeding
- Are not trained in research handling or injection protocols
Warnings and precautions:
- This product is not approved for therapeutic use and is intended for research purposes only
- Not for use in individuals under 18 years of age
- Speak to your research supervisor or healthcare provider if:
- You experience skin reactions at the injection site
- You have a bleeding disorder or are on anticoagulant therapy
- You are taking other peptide therapies
Other substances and BPC157 & TB500: Avoid combining with other peptides or injectables unless part of a structured research protocol.
3. How to use BPC157 & TB500 32
Always use this product exactly as instructed by your protocol or supervising practitioner.
Administration Route: Subcutaneous injection using the prefilled pen.
Dosage Guidance:
- Each pen contains 32 mg (16 mg of each peptide)
- Available doses per injection: 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg
- Standard protocols involve daily or alternate-day administration depending on research focus
- For instance, 0.5 mg selected, delivers 0.5 mg BPC157 and 0.5 mg TB500 per dose
Injection sites:
- Abdomen (at least 5cm from navel)
- Outer thigh
- Back of upper arm
- Rotate sites to avoid irritation
BPC157 & TB500 36 – Suggested Dosage Guidelines
Dosing may vary depending on the purpose of the research or recovery objective:
| Application Area | Suggested Dosage | Frequency |
| Injury Recovery (muscle, tendon, ligament) | 0.75 mg – 1 mg | Daily |
| Joint & Tendon Inflammation | 0.5 mg – 0.75 mg | Daily |
| Gut Healing / GI Repair | 0.25 mg – 0.5 mg | Daily |
| Post-Surgical Recovery | 1 mg | Daily |
| General Regeneration / Anti-inflammatory | 0.5 mg – 0.75 mg | Daily or 5x per week |
Missed dose: If a dose is missed, administer it as soon as possible. Do not double the next dose.
Overdose: No severe outcomes are reported, but high doses may lead to increased fatigue or mild nausea. Consult a professional if overdose is suspected.
4. Possible side effects
Like all research peptides, BPC157 & TB500 may cause side effects, although not everyone will experience them.
Common side effects:
- Mild irritation or redness at injection site
- Fatigue
- Headache
Less common side effects:
- Nausea
- Temporary flushing
Rare side effects:
- Allergic reaction (rash, swelling, dizziness)
- Increased vascularization in specific areas
Reporting side effects: Report all side effects via www.bodypharm.me/contact or to your research authority.
5. How to store BPC157 & TB500 32
- Store in a refrigerator at 2°C to 8°C
- Do not freeze
- Protect from sunlight and heat
- Keep out of reach of children
- Use within 8 weeks of opening
- Keep the pen capped when not in use
- Do not use if the solution appears cloudy or discolored
6. Contents of the pack and other information
What BPC157 & TB500 32 contains:
- Active ingredients: 16mg of Body Protection Compound-157 (BPC-157) & 16mg of Thymosin Beta-4 Acetate (TB-500)
- Excipients: Disodium phosphate dihydrate, Propylene glycol, Phenol, Sterile water
Packaging contents:
- 1 x Prefilled injection pen (32 mg total peptides)
- 8 x sterile injection pen needles
Product form: Clear, colorless solution
7. Instructions for Use
Using the BPC157 & TB500 32 Pen:
- Prepare your pen: Wash your hands. Check the name and colored label on the pen to make sure you have the correct peptide. Do not use the pen if the solution looks cloudy or discolored.
- Attach a new needle: Remove the pen cap. Wipe the rubber seal with an alcohol swab. Attach a new needle to the pen.
- Prime your pen (for first use only): Turn the dose selector to 0.25 mg. Hold the pen with the needle pointing up and press the injection button until a drop of liquid appears at the needle tip.
- Select your dose: Turn the dose selector to the correct dose: 0.25 mg, 0.5 mg, 0.75 mg, or 1 mg as prescribed by your doctor.
- Inject your dose: Choose an injection site (upper arm, abdomen, or thigh). Clean the site with an alcohol swab. Insert the needle into your skin and press the injection button. Hold the button until the dose counter returns to “0”. Keep the needle in the skin for 5 seconds to ensure the full dose is delivered.
- Dispose of the needle: Remove the needle and dispose of it in a sharps container. Replace the pen cap.
Important Tips:
- Storage: Keep the pen in the refrigerator (2°C to 8°C) before first use. After the first use, you can keep the pen at a temperature below 8°C or in the refrigerator.
- Handling: Always attach a new needle before each injection and remove it after the injection to avoid contamination and ensure a sterile needle for each dose.
- Rotation of Injection Sites: Rotate your injection sites to avoid skin irritation. Do not inject in the same spot consecutively.
- Missed Dose: If you miss a dose and it is less than 48 hours late, inject it as soon as you remember on the day.
